Is Lenskart IPO hype masking value? A tight thread of posts flags red flags, insider exit risk, and hype-driven demand that fuels crowd psychology around the giant ₹70,000 crore plan [1]. At the center: can valuations justify growth, or is it a listing-day party dressed as a long-term bet?
Red flags to watch — The case for caution is built on hard numbers: a ~285x valuation to earnings (vs. sector ~43x) and a risk of promoter/early investor exits via OFS rather than pure growth funding [1]. Critics question TAM assumptions (India’s eyewear market vs. the IPO ask) and warn that hype can price in unrealistic gains. Veteran investor Shankar Sharma puts it plainly: “India is dumbest IPO market … there is a sucker born every microsecond.” This isn’t a call for no faith, it’s a plea for skepticism [1].
Hype vs. signal in the market pulse — The discussions relentlessly surface listing-day dynamics: crowd-driven demand, and talk that GMP (Grey Market Premium) can distort timing more than value. In forums, GMP signals are treated as one indicator among many, with some arguing the number 20% can mislead if fundamentals don’t follow [2].
On-the-ground observations — A meme-like counterpoint questions the appeal of the real business, noting that a crowded store and glossy valuations may not reflect earnings power; the battle lines lean on whether the real vision is in glasses or in valuations LENSKRAFT competition scrutiny [3].
Where the debate lands — Some posters prepared to subscribe, citing over-subscription and retail interest; others warn that enthusiasm could fade on listing day or soon after [4]. A cautionary post adds that desperation in IPO marketing isn’t a new phenomenon—and investors should beware [5].
Bottom line: hype can lift the ticker, but true value lives in earnings, margins, and scalable growth beyond launch-day euphoria.
References
Lenskart IPO is a red flag to investors
Discusses Lenskart IPO red flags: inflated valuation, insider exit risk, optimistic TAM, hype-driven demand, potential listing correction for retail investors.
View sourcelenskart sham
GMP indicator discussed; focus on listing gains, long-term hold; questions about signals, market sentiment, and company analysis.
View sourceLenskart's Competitor: LENSKRAFT
Discusses Lenskart's huge ₹70,000 crore IPO, questions crowd, argues discounts mask value, suggesting the real vision lies in valuations today
View sourceHow many planning to invest in Lenskart ipo?
Discussion on investing in Lenskart IPO; over-subscription noted; investors discuss plans and potential listing gains
View sourceNo, They can't get desperate anymore
Discusses Indian IPO advertising law, critique of valuations, urges due diligence, recognizes exits for promoters, investors beware, and easy money.
View source